NCT00004871
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Clinical trial condition
Anemia, Refractory
Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.
73 public trials
1 recruiting study
Anemia, Refractory trial results
NCT00003187
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States
- University of Minnesota Medical School Minneapolis, Minnesota, United States
Active, Not Recruiting
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
NCT00392353
- Conditions
- Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
- North Shore University Hospital Manhasset, New York, United States
- Mount Sinai Hospital New York, United States